AT 10 আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

at 10

intrapharm laboratories limited - dihydrotachysterol - oral drops solution - 250 microgram/ml - dihydrotachysterol

HYTAKEROL CAPSULE কানাডা - ইংরেজি - Health Canada

hytakerol capsule

sanofi-synthelabo canada inc - dihydrotachysterol - capsule - .125mg - dihydrotachysterol .125mg - vitamin d

Cal.D.Forte নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

cal.d.forte

psm healthcare ltd trading as api consumer brands - colecalciferol 1.25mg equivalent to 50,000 iu (plus 12% (0.15 mg) overage) - coated tablet - 1.25 mg - active: colecalciferol 1.25mg equivalent to 50,000 iu (plus 12% (0.15 mg) overage) excipient: acacia   ammonia solution calcium carbonate   castor oil ether gelatin hydrated silica lactose monohydrate magnesium stearate maize starch     methylated spirits povidone powdered cellulose prepared theobroma purified talc     purified water shellac sucrose   titanium dioxide white beeswax - indicated for treatment of vitamin d deficiency associated with malabsorption in children and/or adult patients. indicated for prevention and treatment of vitamin d deficiency states.

APO-LEVOTHYROXINE levothyroxine sodium 200 microgram un-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 200 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 200 microgram un-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 200 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 150 microgram un-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 150 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 150 microgram un-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 150 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 125 microgram un-coated tablet blister pack অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 125 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.